RxDoctor Payments Data

Fawn Zimmer

Family · Concordia, MONPI 1154792810

Payments from drug & device makers

$2,135in general payments, 2019–2025

Across 114 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$443
  • Johnson & Johnson$192
  • Otsuka America Pharmaceutical, Inc.$187
  • AbbVie$153
  • Neurocrine Biosciences, Inc.$137
  • AstraZeneca$134
  • plus $890 from 20 others

What the payments were for

  • Food & beverage$2,01794%
  • Education$1005%
  • Entertainment$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,135 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide59$62,347
JardianceEmpagliflozin41$36,165
JanuviaSitagliptin Phosphate26$18,397
FarxigaDapagliflozin Propanediol16$14,077
MounjaroTirzepatide13$14,030
Praluent PenAlirocumab22$12,449
MyrbetriqMirabegron23$11,398
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,412
Gabapentin96$1,525
Albuterol Sulfate HfaAlbuterol Sulfate41$980
Potassium Chloride44$906
Atorvastatin Calcium136$810
Losartan Potassium127$771
Duloxetine Hcl27$732
Omeprazole72$707

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$31$62,34759 claims
AstraZenecaFarxiga$134$14,07716 claims
Lilly USA, LLCMounjaro$15$14,03013 claims
Astellas Pharma US IncMyrbetriq$41$11,39823 claims
AbbVieSynthroid$153$55413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.

Other family in Concordia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →